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ABSTRACT
Background: Case control studies that randomly
assign patients with diagnosis of acute appendicitis to
either surgical or non-surgical treatment yield
a relapse rate of approximately 14% at one year. It
would be useful to know the relapse rate of patients
who have, instead, been selected for a given treatment
based on a thorough clinical evaluation, including
physical examination and laboratory results (Alvarado
Score) as well as radiological exams if needed or
deemed helpful. If this clinical evaluation is useful, the
investigators would expect patient selection to be
better than chance, and relapse rate to be lower than
14%. Once the investigators have established the
utility of this evaluation, the investigators can begin to
identify those components that have predictive value
(such as blood analysis, or US/CT ﬁndings). This is the
ﬁrst step toward developing an accurate diagnostic-
therapeutic algorithm which will avoid risks and costs
of needless surgery.
Methods/design: This will be a single-cohort
prospective observational study. It will not interfere
with the usual pathway, consisting of clinical
examination in the Emergency Department (ED) and
execution of the following exams at the physician’s
discretion: full blood count with differential, C reactive
protein, abdominal ultrasound, abdominal CT. Patients
admitted to an ED with lower abdominal pain and
suspicion of acute appendicitis and not needing
immediate surgery, are requested by informed consent
to undergo observation and non operative treatment
with antibiotic therapy (Amoxicillin and Clavulanic
Acid). The patients by protocol should not have
received any previous antibiotic treatment during the
same clinical episode. Patients not undergoing surgery
will be physically examined 5 days later. Further
follow-up will be conducted at 7, 15 days, 6 months
and 12 months. The study will conform to clinical
practice guidelines and will follow the recommendations
of the Declaration of Helsinki. The protocol was
approved on November 2009 by Maggiore Hospital
Ethical Review Board (ID CE09079).
Trial Registration: ClinicalTrials.gov identiﬁer:
NCT01096927.
BACKGROUND
Acute appendicitis is one of the most
common urgent conditions seen in general
surgery practice. Complications can be severe
and include perforation and generalised
peritonitis. Traditionally, surgical appendec-
tomy has been the primary treatment, even in
cases of unconﬁrmed diagnosis, given the low
incidence of major complications. However,
in 15e30% of cases the appendix is found to
be free of disease upon resection.
1 2 As
appendectomy is associated with surgical
wound infection, intestinal obstruction due
to adhesions, pneumonia, and tubal infer-
tility in females, the possibility of using
conservative treatment merits investigation.
Non-operative treatment of a suspected
appendicitis has safety implications. Delaying
surgery may increase the risk of perforated
appendicitis, intra-abdominal abscesses, and
localised or diffuse peritonitis before surgery
and wound infection, increased risk of adhe-
sions and subsequent adhesive small bowel
obstruction (ASBO) and infertility after
surgery. Anaesthesia carries its own risks, and
there can also be intraoperative (vascular
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Open Access Protocollesions, enterotomies, urinary tract lesions, etc), early
surgical postoperative (haematoma/bleeding, colonic
ﬁstula, surgical site infection (SSI), intra-abdominal
abscess, adhesions and ileus/obstruction) with subse-
quentre-operation,latesurgicalpostoperative(adhesions
and subsequent ASBO and tubal infertility, incisional
hernias) and general postoperative complications.
Surgery may be associated with a longer hospital
stay and higher costs compared with NOM with
antibiotics, but delayed treatment and a perforated
appendix may worsen morbidity, duration of sick leave
and costs. However, NOM with antibiotics may be a cost-
effective alternative to surgery in a large percentage of
patients without increasing the risk, and may reduce
hospital stay and costs in both developed and third world
countries.
There is considerable debate regarding the utility of
conservative treatment compared with surgical treat-
ment in some cases of acute appendicitis, as few studies
have addressed this issue to date.
3e5 If conservative
treatment is to be considered, it will be very importance
to make an accurate diagnosis and assessment in
every patient in order to select the most appropriate
treatment.
The idea that appendicitis may resolve spontaneously
is not new. In 1908 Alfred Stengel wrote: “Treated in
a purely medical or tentative manner, the great majority
of patients with appendicitis recover”.
6
Restrained indications with few negative appendecto-
mies are associated with a low incidence of diagnosed
non-perforated appendicitis and a secondary high
proportion of perforated appendicitis, but no increase
in the incidence of perforations.
7 This suggests that
appendicitis in a signiﬁcant number of patients may
resolve undiagnosed. Resolving appendicitis may also be
indicated by a history of recurrent appendicitis, which
can be found in up to 6.5% of patients operated on for
appendicitis.
8
When perforation results from delayed treatment, the
associated increase in morbidity and mortality must be
weighed against the risks of a negative appendectomy.
The excess mortality associated with non-perforated
appendicitis and with negative appendectomy with
a discharge diagnosis of non-speciﬁc abdominal pain,
suggests that appendectomy itself carries risks. The
decrease in mortality that may be achieved by one
prevented perforation is therefore negated by each
negative appendectomy.
9 10
Other reports indicate that immediate appendectomy
can be avoided for at least 24 h without increasing
morbidity if antibiotics are administered.
11 Other
authors suggest that appendectomy may not be necessary
for the majority of patients with acute uncomplicated
appendicitis, as the condition resolves spontaneously in
many patients and in others may be treatable with anti-
biotics alone.
12 This approach has many advantages,
including high success and low recurrence rates, reduced
morbidity and mortality, less pain, shorter hospitalisation
and sick leave, and reduced costs.
13
In light of this, routine interval appendectomy after
initial successful conservative treatment does not seem
justiﬁed and should be abandoned. In fact, traditional
interval appendectomy may prevent recurrent appendi-
citis in only 6.7% of patients after conservative treatment
of acute appendicitis with an appendiceal mass. Thus
93.3% would have an unnecessary appendectomy.
14
A recent meta-analysis comparing conservative treat-
ment with acute appendectomy for complicated
ARTICLE SUMMARY
Article focus
- Acute appendicitis can have severe complications including
perforation and generalised peritonitis.
- The appendix is found to be free of disease in 15e30% of
appendectomies.
- As surgery carries various risks, conservative non-surgical
treatment with antibiotics for suspected appendix inﬂammation
may avoid needless surgery, in particular as the relapse rate is
low and the rate of complications is similar.
Key messages
- Case control studies that randomly assign patients with acute
appendicitis to either surgical or non-surgical treatment show
a relapse rate of approximately 14% at 1 year.
- The relapse rate of patients who are treated based on
a thorough clinical evaluation should be below 14%.
- Once factors predictive of outcome and/or the need of surgery
are identiﬁed, an accurate diagnostic-therapeutic algorithm
which will help avoid the risks and costs of needless surgery
can be developed.
Strengths and limitations of this study
- This non-randomised controlled study will evaluate
the effectiveness and short and long term outcomes of non-
operative antibiotic treatment of acute appendicitis.
- Amoxicillin and clavulanic acid are common and easily
managed low cost drugs, available both for intravenous and
oral use.
- Better analysis of clinical data might lead to better decision-
making in patients with right iliac fossa pain and suspected
acute appendicitis.
- The study also aims to evaluate the Alvarado score, which is
used to diagnose acute appendicitis and discriminate patients
needing immediate surgery from patients who may safely
undergo observation and antibiotic treatment.
- A large sample of patients undergoing non-operative antibiotic
treatment will allow a statistically powerful evaluation of safety,
efﬁcacy and cost.
- An additional objective is to identify clinical, laboratory and
imaging ﬁndings that are predictive of failure of conservative
treatment and/or relapse of appendicitis and need for
appendectomy within 1 year.
- As efﬁcacy can not be reliably determined in the absence of
a control group, a case series observation determining
‘efﬁcacy’ has limited value.
- The Alvarado score is used to separate those with acute
appendicitis from those with similar symptoms but
no appendicitis and there is no evidence that this score can
identify those who would beneﬁt from antibiotic treatment.
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The NOTA study: study protocolappendicitis (abscess or phlegmon) and including 1572
patients (847 patients received conservative treatment
and 725 had acute appendectomy) showed that conser-
vative treatment was associated with signiﬁcantly fewer
overall complications, wound infections, abdominal/
pelvic abscesses, ileus/bowel obstructions and re-opera-
tions. Furthermore, there were signiﬁcantly fewer overall
complications in conservative treatment groups during
sensitivity analysis of studies including only paediatric
patients, high-quality studies, more recent studies, and
studies with larger groups of patients.
15
In particular, a randomised clinical trial (RCT) of
antibiotic therapy versus appendicectomy as primary
treatment of acute appendicitis in unselected patients
showed that treatment efﬁcacy was 90.8% for antibiotic
therapy and 89.2% for surgery. In this trial minor
complications were similar between the groups, while
major complications were threefold higher in patients
who had an appendicectomy (p<0.050). In total, 2.9%
of the operated patients underwent a second operation,
3% of them developed abscesses, 2.4% postoperative
small bowel obstruction (SBO), 1.8% wound rupture
or wound hernia, 0.6% pulmonary embolism and
0.6% postoperative cardiac complications, and 1.2%
underwent subsequent ileocaecal resection. Wound
infection occurred in 7.6% and 1.2% of the patients had
anaesthesia-related problems.
16
In another RCT comparing appendectomy with anti-
biotic treatment in acute appendicitis, the complication
rate in the surgery group was 14% (17/124) and was
mainly due to wound infections. In the surgery group,
time in hospital, sick leave taken and time lost from work
were respectively 2.6, 6.0 and 10.1 days.
5
The cumulated risk of surgically treated SBO after
appendicectomy was 0.41% after 4 weeks, 0.63% after
1 year and 1.30% after 30 years of follow-up, compared
with 0.003% at 1 year and 0.21% after 30 years of
follow-up among non-operated controls, with perforated
appendicitis, negative appendicectomy and high age risk
factors for developing subsequent SBO.
17
A further paper reviewing 1777 patients who under-
went appendectomy for acute appendicitis, showed the
overall SBO rate to be 2.8% over an average 4.1-year
follow-up period or 0.0069 cases per person-year.
18
The laparoscopic approach also carries risks, including
intraoperative complications ranging from 3.1% to
0.7%, surgical postoperative complications ranging from
6.1% to 1.9%, general postoperative complications
ranging from 4.9% to 1.5% and rates of re-operations
ranging from 3.4% to 0.7%.
19
A comparison of 3025 open versus 14174 laparoscopic
appendectomies showed SSI occurred in 4% and 1.2%,
deep incisional wound infection in 1.2% and 0.2%,
wound disruption in 0.3% and 0.1%, organ space
infection in 1.3% and 1.7%, pneumonia in 0.6% and
0.3%, renal failure in 0.2% and 0.3%, urinary tract
infection (UTI) in 0.5% and 0.4%, deep vein thrombosis
in 0.4% and 0.1%, sepsis in 1.4% and 1.0% and septic
shock 0.3% and 0.1%, respectively. Appendectomy may
also be associated with mortality (0.3% for open and
0.1% for laparoscopic).
20
Another large population based appraisal including
32683 patients reported morbidity and mortality for
both open and laparoscopic appendectomy.
21 Overall
morbidity was 8.84% and 4.46%, respectively, serious
morbidity 4.23% and 2.58%, SSI 6.65% and 3.26%,
serious morbidity/mortality 4.26% and 2.60%, and
mortality 0.13% and 0.07%. Superﬁcial SSI incidence
was, respectively, 3.89% and 1.26%, deep incisional
SSI 0.99% and 0.24%, organ space SSI 1.72% and
1.79%, wound disruption 0.45% and 0.06%, pneumonia
0.43% and 0.24%, pulmonary embolism 0.08% in both
open and lap groups, sepsis or septic shock 2.16% and
1.15%, bleeding 0.01 and 0.04% and UTIs 0.36% and
0.37%.
The long term follow-up of a RCT of open versus
laparoscopic appendicectomy showed a 42.3% incidence
of overall complications in the open surgery group
versus 12.8% in the laparoscopic group, with wound-
related complications as high as 30.77% versus 4.2%.
22
After a mean follow-up of more than 9 years, 5.7% and
6.4% of patients, respectively, had adhesions or adhe-
sion-related symptoms and 0.2% underwent another
operation for adhesions. The risk of SBO after open
appendectomy is between 0.33 and 1.51%.
Finally, it has been demonstrated that a history of
perforated appendix in childhood does not seem to have
long term negative consequences on female fertility.
This may have important implications for the manage-
ment of young women with suspected appendicitis as the
liberal attitude to surgical exploration with a subse-
quently high rate of removal of a normal appendix is no
longer justiﬁed by a perceived increased risk of infertility
after perforation.
23
In addition, a liberal attitude to exploration among
patients with suspected appendicitis does not prevent
perforations.
24
Hansson et al
16 conducted a RCT investigating the
efﬁcacy of conservative treatment compared to surgery
for acute appendicitis. They reported that conservative
treatment with antibiotics was efﬁcacious in 91% of
cases, with a 14% relapse rate at 12-month follow-up.
One third of relapses occurred within the ﬁrst 10 days of
hospital discharge, while most of the remaining two
thirds occurred between 3 and 16 months following
discharge. The rates of minor complications such as
diarrhoea, vomiting and nosocomial infections were
similar among patients treated conservatively and those
treated surgically. The incidence of major complications
such as appendiceal abscess, paralytic ileus and pulmo-
nary embolism, however, was signiﬁcantly higher in
those treated surgically (p<0.05).
A recent prospective randomised study conducted by
Malik A and colleagues
1 compared antibiotic therapy to
appendectomy in acute appendicitis. The authors
reported that conservative treatment was not only safe
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The NOTA study: study protocoland efﬁcacious, but also caused the patients less pain
than surgery, reducing the need for analgesia (p<0.001).
Ten per cent of conservatively treated patients relapsed
within 12 months of discharge.
A multicentre randomised trial conducted in
Sweden
16 yielded similar results: the rate of relapse in
antibiotic treated patients was 14% at 1 year after
discharge. Interestingly, this was equal to the rate of post-
operative complications in patients treated surgically.
Based on these reports, with the diagnostic accuracy of
acute appendicitis being as high as 71%e87% with
a combination of modern preoperative investigations,
25
conservative treatment with antibiotics seems to valid for
cases of suspected or probable/proven acute appendi-
citis. Relapse rate is low and complications are no higher
than the rate of surgical complications.
RATIONALE
Case control studies that randomly assign patients with
suspected acute appendicitis to either surgical or non-
surgical treatment show a relapse rate of approximately
14% at 1 year. It would, therefore, be useful to deter-
mine the relapse rate of patients treated according to
the results of a thorough clinical evaluation, including
physical examination and laboratory results (all char-
acteristics used to determine the Alvarado score
26)a s
well as radiological evaluation. Imaging such as ultra-
sound may be helpful but is not usually necessary in
diagnosing acute appendicitis and deciding its further
treatment (operative or non-operative). As the Alvarado
and AIR
27 scores are based only on clinical and labora-
tory characteristics, only clinical signs and symptoms
and laboratory values are routinely evaluated in patient
with suspected acute appendicitis. If this clinical evalu-
ation is effective, we would expect patient selection to be
better than chance, and the relapse rate to be below
14%. Once we have established the utility of this evalu-
ation, we can begin to identify those components that
have predictive value (such as blood chemistry analysis
or CT ﬁndings). This would be a ﬁrst step towards
developing an accurate diagnosticetherapeutic algo-
rithm which could be used to avoid the risks and costs of
needless surgery.
Much research into the cause of diseases relies on
cohort, caseecontrol or cross-sectional studies. Obser-
vational studies also have a role in research into the
beneﬁts and harms of medical interventions. Rando-
mised trials cannot answer all important questions about
a given intervention. For example, observational studies
are more suitable for detecting rare or late adverse
effects of treatments, and are more likely to provide an
indication of what is achieved in daily medical practice.
28
STUDY DESCRIPTION
This will be a single-cohort prospective observational
study. Patients presenting to the emergency department
will undergo some or all of the following tests: complete
blood count with differential, C reactive protein,
abdominal ultrasound and abdominal CT scan. Patients
with lower abdominal pain and suspicion of acute
appendicitis not requiring immediate surgery, will
be requested to undergo observation and non-operative
treatment with antibiotic therapy (amoxicillin and
clavulanic acid) and provide informed consent.
Suspected acute appendicitis is deﬁned as patient
presenting with right iliac fossa (RIF) pain AND absence
of a deﬁnite alternative diagnosis, either of a gastroin-
testinal disease (such as inﬂammatory bowel disease
(IBD), irritable bowel syndrome, colitis, etc) or urinary
tract disease (such as UTI, renal colic, urinary tract
stones, etc) or an obstetric-gynaecological cause (such as
pregnancy, pelvic inﬂammatory disease, ovulation, etc).
Patients needing immediate surgery are deﬁned as
those with diffuse peritonitis and/or signs of sepsis, as
well as patients with clinico-radiological (US or CTscan)
evidence of an intra-abdominal collection/abscess.
The patients by protocol should not have received any
previous antibiotic treatment during the same clinical
episode. Patients not undergoing surgery will be physi-
cally examined 5 days later. If their condition has not
improved or worsened, they will be admitted for surgical
appendectomy. If they have improved, they will be given
information about the study and invited to participate,
and asked to sign an informed consent form for further
follow-up. If the patient is under the age of 18 years,
consent will be obtained from a parent or other legal
guardian.
Telephone (or email) follow-up will be conducted at 7
and 15 days, 6 months and 1 year (see ﬁgure 1). In the
case of patients under the age of 18 years, the phone
interview will be conducted with a parent or legal
guardian. The patient will be asked if he/she has
undergone surgery since the ﬁrst visit (5 days after
presenting to the emergency department). If not, the
patient will be asked:
1. Has your illness improved, stayed the same, or
worsened since its onset?
2. Have you undergone any further tests or had
additional doctor’s visits for your illness?
3. After your initial emergency department visit, how
long did it take to return to your normal activities
(physical activity, work, etc)?
STATISTICAL ANALYSIS
Data will be entered into a spreadsheet using Epi-Info
(v 6.04d, Centers for Disease Control and Prevention)
and analysed using SPSS software (v 15.0, SPSS).
Descriptive statistics will be reported as mean and SD for
normally distributed variables and median and IQR for
variables not normally distributed. The c
2 analysis of
variance will be used to compare differences for cate-
gorical variables. ORs with 95% CIs will be calculated.
Student’s paired sample t test will be used to compare
mean differences between continuous variables. The
ManneWhitney U test will be used to compare non-
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count). Statistical signiﬁcance will be deﬁned as p<0.05.
Variables with clinically relevant cut-off points will be
dichotomised.
In order to determine independent predictors of the
short and long term efﬁcacy of antibiotic treatment (in
terms of failure rate of conservative treatment, recur-
rence rate of clinical episodes of acute appendicitis and
deﬁnite improvement without need for surgery within
1 year of follow-up) in the general study population,
numerous variables will be assessed including demo-
graphic characteristics (sex, age), clinical features (past
medical history, gynaecological status, IBD history),
clinical status (body temperature), laboratory studies
(white cell count, neutrophils count, C reactive protein),
whether or not empiric antibiotics were previously
administered, and time to administration and duration
of treatment with amoxicillin and clavulanic acid.
Univariate analyses will be used to identify which
variables with a p value less than 0.20 should be included
in the multivariate models. Stepwise backward logistic
regression will be used to determine whether
these covariates are independent predictors of treatment
efﬁcacy; covariates will be eliminated when p values are
greater than or equal to 0.05.
The same methods will be used to assess predictors of
abdominal pain after discharge, length of hospital stay,
number of outpatient clinic follow-up appointments and
sick leave.
Finally, cost analysis will be carried out on antibiotic
course, length of hospital stay, outpatient clinic follow-up
appointments and sick leave days.
STUDY OBJECTIVES
Main objective
The main objective is to evaluate the outcome of patients
treated conservatively and assess the reliability of the
initial clinical evaluation in predicting which conserva-
tively-treated patients should have been treated surgically.
The primary outcomes are:
1. Short term efﬁcacy of antibiotic treatment: failure of
conservative treatment with 7 days of amoxicillin and
clavulanic acid therapy, deﬁned as readmission due to
lack of clinical improvement and/or worsening
abdominal pain and/or localised/diffuse peritonitis.
2. Long term efﬁcacy of antibiotic treatment: efﬁcacy of
antibiotic therapy for acute appendicitis deﬁned as
incidence of recurrences of clinical episodes of
appendicitis up to follow-up at 1 year (at 7 days,
15 days, 6 months, 1 year).
3. Long term efﬁcacy of antibiotic treatment (no need
for surgery): efﬁcacy of antibiotic therapy for acute
appendicitis deﬁned as deﬁnite improvement without
the need for surgery up to follow-up at 1 year (at
7 days, 15 days, 6 months, 1 year).
4. Safety of antibiotic treatment: major side effects/
drug- or treatment-related complications (ie, allergy
or other treatment-related complications such as
abscess formation).
The secondary outcomes are:
1. Minor complications: minor side effects/drug-
or treatment-related complications (ie, bloating,
diarrhoea, ﬂatulence, headache, heartburn, nausea
and vomiting) (at 7 days, 15 days).
2. Abdominal pain after discharge: assessment of
abdominal pain/discomfort evaluated by means of a
numerical rating scale (at 7 days, 15 days).
3. Length of hospital stay: length of clinical observation
as an inpatient for non-operated patients.
4. Outpatient clinic follow-up: number of follow-up
appointments scheduled in the outpatient clinic.
5. Sick leave: number of days of sick leave needed by the
patient.
6. Cost analysis: analysis of the costs of antibiotics,
length of hospital stay, outpatient clinic follow-up
appointments and sick leave days.
Secondary objective
An additional objective is to identify clinical, laboratory
and imaging ﬁndings that are predictive of failure of
conservative treatment and/or relapse of appendicitis
and need for appendectomy within 1 year.
STUDY DESIGN
This is a single cohort prospective non-randomised
observational study. No experimental interventions or
treatments will be employed beyond routine clinical
care.
A ﬂowchart of the study is given in ﬁgure 2 and
a tempogram showing the study steps is given in ﬁgure 1.
Figure 1 Non-operative
treatment for acute appendicitis:
patient outcomes and follow-up in
a single-cohort prospective
observational study. Flow diagram
of the study according to
CONSORT 2010.
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The NOTA study: study protocolESTIMATED ENROLMENT AND STUDY DATES
The estimated sample size of the study population is
160 patients in 1 year, which is the average number
of patients assessed annually by the emergency surgical
team in our hospital for suspected acute appendicitis,
conservatively treated with antibiotics and observed.
The crude incidence of acute appendicitis is 86 per
100000 inhabitants per year, varying between 74 and
96 per 100000 during a 5-year period in Norway in an
urban and rural catchment area with 265000 inhabitants.
A peak incidence of acute appendicitis was found in
patients13e40 yearsofage,withmoremalesthanfemales
inthisagegroup(ratio1.34:1.00).Amongyoungchildren
and theelderly,signiﬁcantly (p¼0.002)morefemales had
acute appendicitis.
29 A further paper reported the inci-
dence of appendicitis to be about100 per 100000 person-
years in Europe/America.
30
The appendectomy rate continues to decrease,
although the incidence of appendicitis is now nearly
stable and the incidence of perforated appendicitis has
not changed (approximately 20 per 100000 person-
years) over the last 30 years. These data suggest the rate
of surgery for acute appendicitis is decreasing in an
attempt to avoid unnecessary appendectomies.
The catchment population of Bologna is half
a million people. Maggiore Hospital is the largest
hospital in the city and covers the northern area.
The numbers of patients aged over 14 years admitted
to the emergency department with right iliac fossa
pain and/or suspected appendicitis have been moni-
tored for the last 3 years and range from 328 to 443
cases/year.
The study start date is January 2010, the estimated
study completion date is December 2010 and the esti-
mated primary date of completion of follow-up is
December 2011 (the ﬁnal data collection date for all
primary outcome measures and 1 year follow-up).
INCLUSION AND EXCLUSION CRITERIA
Any patient, male or female, above the age of 14 years
(non-paediatric), who returns for a follow-up visit 5 days
after an emergency department visit and consents to
participation between 1 January 2010 and 31 December
2010 will be eligible for inclusion in the study.
Speciﬁcally, the inclusion criteria are:
1. Age >14 years
2. Lower/right iliac fossa abdominal pain
3. Clinical suspicion of acute appendicitis, that is:
eAlvarado score 5e6 (equivocal for acute appendicitis)
eAlvarado score 7e8 (probable appendicitis)
eAlvarado score 9e10 (highly probable appendicitis)
4. Informed consent (patient or legal representative).
Figure 2 CONSORT 2010 ﬂow
diagram.
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The NOTA study: study protocolTable 1 STROBE 2007 (v4) StatementdChecklist of items that should be included in reports of caseecontrol studies
Item # Recommendation Reported on page #
Title and abstract 1 (a) Indicate the study’s design with a commonly
used term in the title or the abstract
2e3
(b) Provide in the abstract an informative and
balanced summary of what was done what was
found
2e3
Introduction
Background/
rationale
2 Explain the scientiﬁc background and rationale
for the investigation being reported
5e10
Objectives 3 State speciﬁc objectives, including any
prespeciﬁed hypotheses
12e14
Methods
Study design 4 Present key elements of study design early in
the paper
14
Setting 5 Describe the setting, locations, and relevant
dates, including periods of recruitment,
exposure, follow-up, and data collection
10e11/14e16
Participants 6 (a) Give the eligibility criteria, and the sources
and methods of case ascertainment and control
selection. Give the rationale for the choice of
cases and controls
15
(b) For matched studies, give matching criteria
and the number of controls per case
Variables 7 Clearly deﬁne all outcomes, exposures,
predictors, potential confounders, and effect
modiﬁers. Give diagnostic criteria, if applicable
10e11/12e14
Data sources/
measurement
8* For each variable of interest, give sources of
data and details of methods of assessment
(measurement). Describe comparability of
assessment methods if there is more than one
group
11e12
Bias 9 Describe any efforts to address potential
sources of bias
4
Study size 10 Explain how the study size was arrived at 14
Quantitative
variables
11 Explain how quantitative variables were handled
in the analyses. If applicable, describe which
groupings were chosen and why
11e12
Statistical methods 12 (a) Describe all statistical methods, including
those used to control for confounding
11e12
(b) Describe any methods used to examine
subgroups and interactions
11e12
(c) Explain how missing data were addressed 11e12
(d) If applicable, explain how matching of cases
and controls was addressed
11e12
(e) Describe any sensitivity analyses 11e12
Results
Participants 13* (a) Report numbers of individuals at each stage
of studydfor example, numbers potentially
eligible, examined for eligibility, conﬁrmed
eligible, included in the study, completing
follow-up, and analysed
Not yet applicable
(b) Give reasons for non-participation at each
stage
Not yet applicable
(c) Consider use of a ﬂow diagram Not yet applicable
Descriptive data 14* (a) Give characteristics of study participants (eg,
demographic, clinical, social) and information on
exposures and potential confounders
Not yet applicable
(b) Indicate number of participants with missing
data for each variable of interest
Not yet applicable
Continued
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1. Diffuse peritonitis
2. Antibiotic (penicillin) documented allergy
3. Ongoing previously commenced antibiotic therapy
4. Previous appendectomy
5. Positive pregnancy test
6. IBD history or suspicion of IBD reoccurrence.
Follow-up assessment will be by telephone interview
(or email). No interviewer training will be necessary as
the surgeons conducting the study will also conduct the
phone interviews. Informed consent will be obtained
from the patient (or guardian) before enrolling him/
her in the study. Conﬁdentiality of personal and health
information will be guaranteed and will only be accessible
to the surgeons responsible for the study. Members of the
project management team are as follows: study chair:
Gregorio Tugnoli, MD; principal investigators: Salomone
Di Saverio MD, Eleonora Giorgini MD, Nicola Antonacci,
MD, Andrea Biscardi, MD, Nicola Clemente MD and
Silvia Villani MD. The over-seeing authority is the Bologna
Local Health District Ethics Committee (approval
number CE 09079). The study follows the recommenda-
tions of the Declaration of Helsinki
31 and conforms with
the accepted best practice guidelines of the STROBE
statement for observational studies (cohort, caseecontrol
or cross-sectional designs)
32 (table 1).
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1Department of Emergency, Emergency Surgery and Trauma Surgery Unit,
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Italy
2Division of Minimally Invasive and Endocrine Surgery, Department of
Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, New
York, New York, USA
3University of Naples Federico II, Department of General and Gastrointestinal
Surgery, Naples, Italy
Acknowledgements The authors would like to acknowledge the head of the
Department of Emergency of the Bologna Local Health District, Dr Giovanni
Table 1 Continued
Item # Recommendation Reported on page #
Outcome data 15* Report numbers in each exposure category, or
summary measures of exposure
Not yet applicable
Main results 16 (a) Give unadjusted estimates and, if applicable,
confounder-adjusted estimates and their
precision (eg, 95% CI). Make clear which
confounders were adjusted for and why they
were included
Not yet applicable
(b) Report category boundaries when continuous
variables were categorized
Not yet applicable
(c) If relevant, consider translating estimates of
RR into absolute risk for a meaningful time
period
Not yet applicable
Other analyses 17 Report other analyses donedfor example,
analyses of subgroups and interactions, and
sensitivity analyses
Not yet applicable
Discussion Not yet applicable
Key results 18 Summarise key results with reference to study
objectives
Not yet applicable
Limitations 19 Discuss limitations of the study, taking into
account sources of potential bias or imprecision.
Discuss both direction and magnitude of any
potential bias
Not yet applicable
Interpretation 20 Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Not yet applicable
Generalisability 21 Discuss the generalisability (external validity) of
the study results
Not yet applicable
Other information Not yet applicable
Funding 22 Give the source of funding and the role of the
funders for the present study and, if applicable,
for the original study on which the present article
is based
16
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and
cross-sectional studies.
An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of
transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at
http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information
on the STROBE Initiative is available at http://www.strobe-statement.org/.
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